David Hering
Net worth: 35 520 $ as of 31/03/2024
Profile
David Hering is Chief Operating Officer at Adagio Therapeutics, Inc. He previously held the position of Head-Franchise Business at Pfizer Inc. and Head-North America Region at Novartis Vaccines & Diagnostics, Inc. Mr. Hering received an MBA from Harvard Business School and an undergraduate degree from Cornell University.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
INVIVYD, INC.
0.01% | 18/12/2023 | 8,000 ( 0.01% ) | 35 520 $ | 31/03/2024 |
Former positions of David Hering
Companies | Position | End |
---|---|---|
INVIVYD, INC. | Chief Executive Officer | 11/04/2024 |
PFIZER, INC. | Corporate Officer/Principal | 01/06/2021 |
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Corporate Officer/Principal | - |
Training of David Hering
Cornell University | Undergraduate Degree |
Harvard Business School | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 2 |
---|---|
PFIZER, INC. | Health Technology |
INVIVYD, INC. | Health Technology |
Private companies | 1 |
---|---|
Novartis Vaccines & Diagnostics, Inc.
Novartis Vaccines & Diagnostics, Inc. Pharmaceuticals: MajorHealth Technology Novartis Vaccines & Diagnostics, Inc. manufactures and markets health care and nutritional products. The company was founded in 1986 and is headquartered in East Hanover, NJ. | Health Technology |
- Stock Market
- Insiders
- David Hering